Skip to main content

(Approval lapsed) QLAIRA estradiol valerate/dienogest film-coated tablets composite pack in wallet pack (Bayer plc UK)

Section 19A approved medicine
(Approval lapsed) QLAIRA estradiol valerate/dienogest film-coated tablets composite pack in wallet pack (Bayer plc UK)
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 516
Phone
1800 181 060
Approved until
Status
Expired
Medicines in short supply/unavailable
QLAIRA estradiol valerate / dienogest tablets composite pack in wallet pack - ARTG 149319
Indication(s)
  • Oral contraception
  • Treatment of heavy and/or prolonged menstrual bleeding in women without organic pathology who desire oral contraception.

Help us improve the Therapeutic Goods Administration site